Skip to main navigation Skip to search Skip to main content

Gut microbiota and metabolic disorders

Research output: Contribution to journalArticlepeer-review

Abstract

Gut microbiota plays critical physiological roles in the energy extraction and in the control of local or systemic immunity. Gut microbiota and its disturbance also appear to be involved in the pathogenesis of diverse diseases including metabolic disorders, gastrointestinal diseases, cancer, etc. In the metabolic point of view, gut microbiota can modulate lipid accumulation, lipopolysaccharide content and the production of short-chain fatty acids that affect food intake, inflammatory tone, or insulin signaling. Several strategies have been developed to change gut microbiota such as prebiotics, probiotics, certain antidiabetic drugs or fecal microbiota transplantation, which have diverse effects on body metabolism and on the development of metabolic disorders.

Original languageEnglish
Pages (from-to)198-203
Number of pages6
JournalDiabetes and Metabolism Journal
Volume39
Issue number3
DOIs
StatePublished - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Gut
  • Metformin
  • Microbiota
  • Obesity

Fingerprint

Dive into the research topics of 'Gut microbiota and metabolic disorders'. Together they form a unique fingerprint.

Cite this